Skip to main content

Table 2 Data monitoring committee members

From: Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

NameRolePosition
Jieming QuChairProfessor of Respiratory Medicine & President, Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Weichung Joe ShihMemberDirector of Biometrics Division of the Cancer Institute of New Jersey, Rutgers University
Rob FowlerMemberSenior scientist, Evaluative Clinical Sciences, Trauma, Emergency & Critical Care Research Program, Sunnybrook Research Institute, Toronto, Canada
Rory CollinsMemberHead, Nuffield Department of Population Health, University of Oxford, UK
Chen YaoMemberBiometrics Division of Peking University